Skip to content

Study on Symptom Clusters During Chemotherapy in Ovarian Cancer Patients With Different Chinese Medicine Constitution

Correlation Study of Symptom Clusters and Negative Emotions During Chemotherapy in Ovarian Cancer Patients With Different Chinese Medicine Constitution

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06222008
Enrollment
40
Registered
2024-01-24
Start date
2022-01-30
Completion date
2024-06-30
Last updated
2024-01-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ovarian Cancer, Radiotherapy Side Effect, Symptom Cluster

Brief summary

The goal of this observational study is to learn about in Patients treated with postoperative chemotherapy for ovarian tumors. The main questions it aims to answer are: • \[What symptom clusters are present in patients treated with postoperative chemotherapy for ovarian tumors\] • \[Are there differences in symptom clusters for patients with different TCM body types\] Participants will \[complete questionnaires prior to the start of chemotherapy and after the 1st, 3rd, and 6th chemotherapy treatments\].

Interventions

OTHERno Intervention

Observational study, no intervention

Sponsors

Yandi Zhu
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Pathologic diagnosis of ovarian cancer, the treatment plan adopts surgery combined with chemotherapy. Age ≥ 18 years old, know the real situation of the disease, the expected survival period \> 1 year. General condition is good, no history of psychiatric disease, no serious heart, brain, liver, kidney function abnormality. Informed consent and voluntarily participate in this study.

Exclusion criteria

those who have other tumors or whose diagnosis is unclear. those who cannot communicate properly, understand the questionnaire or complete the scale assessment. those who receive additional psychological interventions during the study period.

Design outcomes

Primary

MeasureTime frameDescription
Chemotherapy SymptomsAverage 1 yearSymptoms during chemotherapy,Examples include nausea, vomiting, hair loss, fatigue , etc.

Secondary

MeasureTime frameDescription
Chemotherapy symptom clustersAverage 1 yearThe internal consistency, content validity, and validity of the scale were verified by combining the 13 core symptom items in the Chinese Version of the M.D. Anderson Symptom Inventory (MDASI-C) with the 9 ovarian cancer-specific symptoms. All entries (22) are numbered 0 to 10 to represent the degree of symptoms from nonexistent to worst imaginable, and the symptoms assessed ranged from nonexistent to worst imaginable. The onset of the assessed symptoms was limited to the last 24 hours.

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026